Skip to content

A verification study on effects of alcohol metabolism improvement: A randomized double-blind crossover trial

A verification study on effects of alcohol metabolism improvement: A randomized double-blind crossover trial - A verification study on effects of alcohol metabolism improvement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026356
Enrollment
15
Registered
2017-03-01
Start date
2017-03-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese adults

Interventions

I. Active beverage II. Positive control beverage 1 III. Positive control beverage 2 IV. Placebo beverage *The intervention sequence is I-IV, and each beverage is single dose *Refrigerate the test

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Seishin-kai Medical Association Inc, Takara Medical Clinic.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese adults 2. Those who is able to drink whisky (alcohol: 18%) 3. Those who have a low tolerance of alcohol 4. Those who are considered as appropriate for the study by the physician 5. The area under the blood ethanol concentration-time curve (TAUC) is relatively large

Exclusion criteria

Exclusion criteria: 1. At least one previous medical history or under the treatment of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases 3. Those who use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily 4. Currently taking medicines and/or herbal medicines 5. Those who are allergic to medicines and/or the test food related products 6. Those who are pregnant, breast-feeding, and plan to become a pregnant 7. Those who had participated another clinical test for three months when you signed the informed consent form for this trial 8. Others considered as inappropriate for the study by the physician

Design outcomes

Primary

MeasureTime frame
1. Blood ethanol concentration *Take blood samples before drinking alcohol and at 30, 60, 120, and 180 minutes after *Implement after each single-dose (total 4 times)

Secondary

MeasureTime frame
1. Blood acetaldehyde concentration * Take blood samples before drinking alcohol and at 30, 60, 120, and 180 minutes after *Implement after each single-dose (total 4 times) 2. Questionnaire of subjective symptoms (The Likert scale method) *Fill in the questionnaire 180 minutes after drinking alcohol *Implement after each single-dose (total 4 times)

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026